olanzapine and Mucopolysaccharidosis-III

olanzapine has been researched along with Mucopolysaccharidosis-III* in 1 studies

Other Studies

1 other study(ies) available for olanzapine and Mucopolysaccharidosis-III

Article	Year
Extrapyramidal symptoms and medication use in Mucopolysaccharidosis type III. Journal of intellectual & developmental disability, 2009, Volume: 34, Issue:3 We report the case of a 16-year-old male with Mucopolysaccharidosis III type A (Sanfilippo syndrome) who was commenced on risperidone for behaviour management. He rapidly developed extrapyramidal symptoms that have not resolved.. The medication histories of 20 patients with Mucopolysaccharidosis III seen at a Lysosomal Storage Diseases Clinic were reviewed to determine the incidence of extrapyramidal side effects.. Six patients had been treated with risperidone, olanzapine, or lamotrigine. Five of these patients developed extrapyramidal side effects.. The incidence of extrapyramidal side effects was considerably higher than expected. We suggest that these medications be used with considerable caution in these patients. Topics: Adolescent; Adult; Anticonvulsants; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Child; Child, Preschool; Cohort Studies; Female; Humans; Incidence; Lamotrigine; Male; Mental Disorders; Mucopolysaccharidosis III; Olanzapine; Risperidone; Triazines; Young Adult	2009

Article

Year

Extrapyramidal symptoms and medication use in Mucopolysaccharidosis type III.

Journal of intellectual & developmental disability, 2009, Volume: 34, Issue:3

We report the case of a 16-year-old male with Mucopolysaccharidosis III type A (Sanfilippo syndrome) who was commenced on risperidone for behaviour management. He rapidly developed extrapyramidal symptoms that have not resolved.. The medication histories of 20 patients with Mucopolysaccharidosis III seen at a Lysosomal Storage Diseases Clinic were reviewed to determine the incidence of extrapyramidal side effects.. Six patients had been treated with risperidone, olanzapine, or lamotrigine. Five of these patients developed extrapyramidal side effects.. The incidence of extrapyramidal side effects was considerably higher than expected. We suggest that these medications be used with considerable caution in these patients.

Topics: Adolescent; Adult; Anticonvulsants; Antipsychotic Agents; Basal Ganglia Diseases; Benzodiazepines; Child; Child, Preschool; Cohort Studies; Female; Humans; Incidence; Lamotrigine; Male; Mental Disorders; Mucopolysaccharidosis III; Olanzapine; Risperidone; Triazines; Young Adult

2009